Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
- Resource Type
- Article
- Authors
- O'Riordan, William; Cardenas, Carrie; Shin, Elliot; Sirbu, Alissa; Garrity-Ryan, Lynne ; Das, Anita F; Eckburg, Paul B; Manley, Amy; Steenbergen, Judith N; Tzanis, Evan; McGovern, Paul C; Loh, Evan
- Source
- In The Lancet Infectious Diseases October 2019 19(10):1080-1090
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1473-3099